{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:44:18Z","timestamp":1792226658581,"version":"4.4.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10072-020-04560-w","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:21:09Z","timestamp":1595539269000},"page":"365-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Axonal form of Guillain-Barr\u00e9 syndrome in a patient receiving oxaliplatin-based chemotherapy"],"prefix":"10.1007","volume":"42","author":[{"given":"Linpei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9205-5559","authenticated-orcid":false,"given":"Hongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"4560_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10072-019-04199-2","volume":"41","author":"M Tyberghein","year":"2020","unstructured":"Tyberghein M, Milants C, Bouquiaux O, Wang F (2020) Axonal form of Guillain-Barr\u00e9 syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci 41:1611\u20131613. https:\/\/doi.org\/10.1007\/s10072-019-04199-2","journal-title":"Neurol Sci"},{"key":"4560_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J (2013) Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 24:443\u2013453","journal-title":"Cytokine Growth Factor Rev"},{"key":"4560_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15:671\u2013683","journal-title":"Nat Rev Neurol"},{"key":"4560_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.54.3.620","volume":"54","author":"R Van Koningsveld","year":"2000","unstructured":"Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Mech\u00e9 FG (2000) Mild forms of Guillain-Barr\u00e9 syndrome in an epidemiologic survey in the Netherlands. Neurology 54:620\u2013625","journal-title":"Neurology"},{"key":"4560_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ (2013) Guillain-Barr\u00e9 syndrome and variants. Neurol Clin 31:491\u2013510","journal-title":"Neurol Clin"},{"key":"4560_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","volume":"63","author":"S Kuwabara","year":"2004","unstructured":"Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N (2004) Does Campylobacter jejuni infection elicit \"demyelinating\" Guillain-Barre syndrome? Neurology 63:529\u2013533","journal-title":"Neurology"},{"key":"4560_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10072-017-3025-3","volume":"38","author":"D Franciotta","year":"2017","unstructured":"Franciotta D, Gastaldi M, Benedetti L, Pesce G, Biagioli T, Lolli F, Costa G, Melis C, Andreetta F, Simoncini O, Giannotta C, Bazzigaluppi E, Fazio R, Bedin R, Ferraro D, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Cortese A, Nobile-Orazio E (2017) Diagnostics of dysimmune peripheral neuropathies. Neurol Sci 38:243\u2013247","journal-title":"Neurol Sci"},{"key":"4560_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jneuroim.2005.11.017","volume":"173","author":"RD Lardone","year":"2006","unstructured":"Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA (2006) Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies. J Neuroimmunol 173:174\u2013179","journal-title":"J Neuroimmunol"},{"key":"4560_CR9","doi-asserted-by":"crossref","unstructured":"Gr\u00fcter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I (2020) Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. J Neurol 267:715\u2013720","DOI":"10.1007\/s00415-019-09614-4"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04560-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:44:39Z","timestamp":1626997479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04560-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4560"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04560-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}